½ÃÀ庸°í¼­
»óǰÄÚµå
1373930

¼¼°èÀÇ ¼¼Æ÷ÁÖ °³¹ß ½ÃÀå : Á¦Ç°º°, ¼¼Æ÷ÁÖ À¯Çüº°, ¿ëµµº°, ±¹°¡º°, Áö¿ªº°-»ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À²(2023-2030³â) ¿¹Ãø

Cell Line Development Market, By Product, By Type of Cell Lines, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: AnalystView Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® 333 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¼¼Æ÷ÁÖ °³¹ß(Cell Line Development) ½ÃÀå ±Ô¸ð´Â 2022³â 48¾ï 1,000¸¸ ´Þ·¯¿¡¼­ 2023³âºÎÅÍ 2030³â±îÁö CAGR 9.81%·Î ÃßÀÌÇÏ¸ç ¼ºÀå ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼Æ÷ÁÖ °³¹ß ŸÄÏ ½ÃÀå-½ÃÀå ¿ªÇÐ

¹ÙÀÌ¿ÀÀǾàǰ°ú ¸ÂÃãÇü ÀÇ·á ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ö¿ä¸¦ ÃËÁø

¹ÙÀÌ¿À ÀǾàǰ »ê¾÷ÀÇ È®´ë´Â ´ÜŬ·ÐÇ×ü ¹× À¯ÀüÀÚ Ä¡·á¿Í °°Àº º¹ÀâÇÑ ¹ÙÀÌ¿À ÀǾàǰÀÇ »ý»ê¿¡ ÀûÇÕÇÑ ½Å·Ú¼º ÀÖ°í »ý»ê¼ºÀÌ ³ôÀº ¼¼Æ÷ÁÖ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸ÂÃãÇü ÀÇ·á°¡ Áß½ÃµÇ°Ô µÊÀ¸·Î½á, ÁÖ¹®Á¦ÀÛÀÇ ÀǾàǰÀ» Á¦ÀÛÇØ, ÀüÀÓ»ó½ÃÇèÀ» ÃËÁøÇϱâ À§ÇÑ È¯ÀÚ Æ¯ÀÌÀû ¼¼Æ÷ÁÖÀÇ Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ¿ä±¸´Â º¸´Ù ź·ÂÀûÀÌ°í ³ôÀº ¼öÀ²·Î ´Ù¸ñÀû ¼¼Æ÷ÁÖ ¼ö¸³À» ¸ñÇ¥·Î ÇÏ´Â ÇöÀç ÁøÇà ÁßÀÎ R&D ³ë·ÂÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú ±¤¹üÀ§ÇÑ Áúº´°ú º´Å¸¦ ´ë»óÀ¸·Î ÇÏ´Â »õ·Î¿î Ç¥Àû Ä¡·áÁ¦ÀÇ Áøº¸¿Í ÀÌ¿ëÀÌ ÃËÁøµË´Ï´Ù.

¼¼Æ÷ÁÖ °³¹ß ½ÃÀå-ÁÖ¿ä ÀλçÀÌÆ®

¿ì¸®ÀÇ ¿¬±¸ ºÐ¼®°¡ÀÇ ¿¬±¸ °á°ú¿¡ µû¸£¸é ¼¼°èÀÇ ¼¼Æ÷ÁÖ °³¹ß ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁöÀÇ ¿¹Ãø ±â°£ µ¿¾È ¾à 4.2%ÀÇ ¿¬°£ ¼ºÀå·üÀ» Àü¸ÁÇϰí ÀÖ½À´Ï´Ù.

¼¼Æ÷ÁÖ °³¹ß ºÐ¾ß´Â ÁÖ·Î ¼öÀÇÇÐ Á¾¾çÇÐ ºÐ¾ß¿¡¼­ Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡·Î ÀÎÇØ Å©°Ô È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç°º° ¼¼ºÐÈ­¿¡¼­ ½Ã¾à°ú ¹èÁö´Â 2022³â ÁÖ¿ä Ä«Å×°í¸®·Î ¶°¿Ã¶ú½À´Ï´Ù.

¼¼Æ÷ÁÖ À¯Çüº°·Î 2022³â Á¦Ç° Ä«Å×°í¸®¿¡¼­ ÀçÁ¶ÇÕ ¼¼Æ÷ÁÖ°¡ ¼±µµÇß½À´Ï´Ù.

Áö¿ªº°·Î´Â ¾Æ½Ã¾Æ ÅÂÆò¾çÀÌ 2022³â ¼öÀÍÀ» À̲ø¾ú½À´Ï´Ù.

¼¼Æ÷ÁÖ °³¹ß ½ÃÀå-¼¼ºÐÈ­ ºÐ¼® :

¼¼°èÀÇ ¼¼Æ÷ÁÖ °³¹ß ½ÃÀåÀº Á¦Ç°, ¼¼Æ÷ÁÖ À¯Çü, ¿ëµµ ¹× Áö¿ªÀ» Æ÷ÇÔÇÑ ¿©·¯ ÁÖ¿ä Â÷¿øÀ¸·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù.

Á¦Ç° ºÐ·ù¿¡¼­ ½ÃÀåÀº ³× °¡Áö ÁÖ¿ä ºÎ¹®·Î ±¸ºÐµË´Ï´Ù : ½Ã¾à, ¹èÁö, Àåºñ, ¾×¼¼¼­¸® ¹× ¼Ò¸ðǰ, ¼­ºñ½º. ƯÈ÷ ½Ã¾à°ú ¹èÁö´Â ÀÌ ºÐ·ù¿¡¼­ ¿ì¼±ÇÕ´Ï´Ù. ¼¼Æ÷ÁÖ °³¹ßÀº ´Ù¾çÇÑ Æ¯¼ö ½Ã¾à°ú ¼¼Æ÷ ¹è¾ç ¹èÁö¿¡ Å©°Ô ÀÇÁ¸ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Çʼö ¼ººÐ ¼ö¿ä´Â ¼¼Æ÷ ¼ºÀå, À¯Áö, »ý»ê¼ºÀ» À§ÇÑ ÀÌ»óÀûÀΠȯ°æÀ» Á¦°øÇÒ Çʿ伺¿¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ÀÌ Á¦Ç°Àº ¿¬±¸ ¹× ¹ÙÀÌ¿À Á¦Á¶ ºÐ¾ß¿¡¼­ Àû¿ëµÇ´Â °íǰÁú ¼¼Æ÷ÁÖÀÇ ¼ö¸³°ú À¯Áö¿¡ ÇʼöÀûÀÎ µµ±¸ÀÔ´Ï´Ù.

¼¼Æ÷ÁÖ °³¹ß ½ÃÀå-Áö¸®Àû ÅëÂû

Áö¸®Àû °üÁ¡¿¡¼­ º¸¸é ÀÌ ½ÃÀåÀº ºÏ¹Ì, ³²¹Ì, À¯·´, ¾Æ½Ã¾Æ ÅÂÆò¾ç, Áßµ¿, ¾ÆÇÁ¸®Ä« µî Æø³ÐÀº Áö¿ªÀ» ¸Á¶óÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª ³»¿¡¼­ °³º° ±¹°¡´Â »ç¾÷ Ȱµ¿À» À°¼ºÇϴµ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¾Æ½Ã¾Æ ÅÂÆò¾ç¿¡¼­´Â ¼¼Æ÷ÁÖ °³¹ß ¼­ºñ½º¿Í Àü¹® Áö½Ä¿¡ ´ëÇÑ ¼ö¿ä°¡ ²ÙÁØÈ÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ µ¿ÇâÀº ¸¹Àº ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ù°, ÀÌ Áö¿ªÀÇ »ý¸í°øÇаú Á¦¾à ºÎ¹®ÀÇ ±Þ¼ºÀåÀº ÀǾàǰÀÇ ¿¬±¸ °³¹ßÀ» ÃËÁøÇϱâ À§ÇÑ ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼¼Æ÷ÁÖ¿¡ ´ëÇÑ Çʿ伺À» ³ôÀ̰í ÀÖ½À´Ï´Ù.

¼¼Æ÷ÁÖ °³¹ß ½ÃÀå-°æÀï ±¸µµ :

¼¼Æ÷ÁÖ °³¹ß°æÀï ±¸µµÀº ÀüÅë ±â¾÷°ú ½ÅÈï ±â¾÷ÀÌ È¥ÇյǾî ÀÖ½À´Ï´Ù. Lonza, Thermo Fisher Scientific, WuXi Biologics¿Í °°Àº ±â¾÷Àº Á¾ÇÕÀûÀÎ ¼­ºñ½º¿Í ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷µéÀº Çõ½Å, ±Ô¸ð, Àü¹® Áö½ÄÀ» ¾îÇÊÇÔÀ¸·Î½á °æÀï¿¡ µµÀüÇϰí ÀÖ½À´Ï´Ù. ÇÑÆí, ¼¿·º½Ã½º¿Í ¼Ò·»ÆÀ°ú °°Àº Áß¼Ò±â¾÷Àº ƯÁ¤ Æ´»õ ½ÃÀå¿¡ ÃÊÁ¡À» ¸ÂÃß¾î Àü¹®È­µÈ ¼Ö·ç¼Ç°ú ÃÖ÷´Ü Ç÷§ÆûÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼Æ÷ÁÖ °³¹ß ½ÃÀå °³¿ä

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ÃßÁ¤ ¿¬µµ

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ºÐ¼®
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå ¼¼Æ÷ÁÖ °³¹ßÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå ¼ºÀå ÃËÁø ¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦ ¿äÀÎ
  • ½ÃÀå ±âȸ
  • ÇâÈÄ ½ÃÀå µ¿Çâ

Á¦4Àå ¼¼Æ÷ÁÖ °³¹ß »ê¾÷ Á¶»ç

  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ¼ºÀå Àü¸Á ¸ÊÇÎ
  • ±ÔÁ¦ Ʋ ºÐ¼®

Á¦5Àå ¼¼Æ÷ÁÖ °³¹ß ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

  • COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
  • COVID-19 ÈÄÀÇ ¿µÇ⠺м®

Á¦6Àå ¼¼Æ÷ÁÖ °³¹ß ½ÃÀå »óȲ

  • ¼¼Æ÷ÁÖ °³¹ß ½ÃÀå Á¡À¯À² ºÐ¼®(2022³â)
  • ÁÖ¿ä Á¦Á¶¾÷üº° ºÐ¼® µ¥ÀÌÅÍ
    • ±âÁ¸ ±â¾÷ ºÐ¼®
    • ½ÅÈï ±â¾÷ ºÐ¼®

Á¦7Àå ¼¼Æ÷ÁÖ °³¹ß ½ÃÀå-Á¦Ç°º°

  • °³¿ä
    • Á¦Ç°º° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ½Ã¾à ¹× ¹èÁö
    • ÀåÄ¡
    • ºÎ¼Óǰ ¹× ¼Ò¸ðǰ
    • ¼­ºñ½º

Á¦8Àå ¼¼Æ÷ÁÖ °³¹ß ½ÃÀå-¼¼Æ÷ÁÖ À¯Çüº°

  • °³¿ä
    • ¼¼Æ÷ÁÖ À¯Çüº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ÀçÁ¶ÇÕ ¼¼Æ÷ÁÖ
    • ÇÏÀ̺긮µå ¸¶½º
    • ¿¬¼Ó ¼¼Æ÷ÁÖ
    • 1Â÷ ¼¼Æ÷ÁÖ

Á¦9Àå ¼¼Æ÷ÁÖ °³¹ß ½ÃÀå-¿ëµµº°

  • °³¿ä
    • ¿ëµµº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • »ý¹°»ý»ê
    • â¾à
    • µ¶¼º½ÃÇè
    • Àΰ£ Á¶Á÷ °øÇÐ
    • ±âŸ

Á¦10Àå ¼¼Æ÷ÁÖ °³¹ß ½ÃÀå-Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
    • °³¿ä
    • ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • °³¿ä
    • À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ·¯½Ã¾Æ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • Æú¶õµå
    • ±âŸ
  • ¾Æ½Ã¾Æ ÅÂÆò¾ç(APAC)
    • °³¿ä
    • ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • Àεµ
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • Àεµ³×½Ã¾Æ
    • Çʸ®ÇÉ
    • ±âŸ
  • ³²¹Ì
    • °³¿ä
    • ³²¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • °³¿ä
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ÅÍŰ
    • ¾ËÁ¦¸®
    • ÀÌÁýÆ®
    • ±âŸ

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼®-¼¼Æ÷ÁÖ °³¹ß »ê¾÷

  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä
    • Lonza
    • Thermo Fisher Scientific
    • WuXi Biologics
    • Catalent
    • Selexis
    • Horizon Discovery
    • Sartorius
    • MilliporeSigma
    • Abcam
    • ATCC
    • Crown Bioscience
    • LakePharma
    • ProBioGen
    • Solentim
    • Horizon Therapeutics

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

LYJ 23.11.13

REPORT HIGHLIGHT

Cell Line Development Market size was valued at USD 4,810 Million in 2022, expanding at a CAGR of 9.81 % from 2023 to 2030.

Cell line development represents a pivotal procedure in the biotechnology and pharmaceutical sectors, involving the creation and curation of specialized cells capable of sustained replication and the expression of desired proteins or traits. Typically, these cells are sourced from either animal or human tissues. These well-established cell lines serve as indispensable tools for research, drug discovery, and the large-scale production of biomanufactured products. The process encompasses cell isolation, modification, and thorough characterization to ensure stability and productivity. Cell lines play an integral role in the manufacturing of biopharmaceuticals, vaccines, and disease-related research, significantly expediting scientific advancements and enabling the efficient development of novel medicines and bioproducts catering to diverse medical and industrial applications.

Cell Line Development Market- Market Dynamics

Growing demand for biopharmaceuticals and personalized medicine propel market demand

The expanding biopharmaceutical industry creates a rising demand for reliable and productive cell lines suitable for the production of complex biotherapeutics, including monoclonal antibodies and gene therapies. Additionally, the emphasis on personalized medicine underscores the necessity for patient-specific cell lines to craft tailored medications and facilitate preclinical testing. This requirement fuels ongoing research and development endeavors aimed at establishing more resilient, high-yield, and versatile cell lines. This, in turn, expedites the advancement and accessibility of novel, targeted therapeutics for a wide spectrum of diseases and medical conditions.

Cell Line Development Market- Key Insights

According to our research analyst's findings, the global Cell Line Development market anticipates an annual growth rate of approximately 4.2% during the forecast period spanning from 2023 to 2030.

The Cell Line Development sector is poised for substantial expansion, primarily attributed to the growing focus on precision medicine within the field of veterinary oncology.

When considering the segmentation by Product, Reagent and Media emerged as the dominant category in the year 2022.

In terms of Type of Cell Lines, Recombinant cell lines took the lead in the Product category in 2022.

Geographically, Asia Pacific led the way in revenue generation in the year 2022.

Cell Line Development Market- Segmentation Analysis:

The global Cell Line Development Market is structured around several key dimensions, including Product, Type of Cell Lines, Application, and Region.

In terms of Product categorization, the market is delineated into four main segments: Reagent and Media, Equipment, Accessories and Consumables, and Services. Notably, Reagent and Media take precedence in this classification. The development of cell lines relies heavily on a variety of specialized reagents and cell culture media. The demand for these essential components is propelled by the necessity to provide an ideal environment for cell growth, maintenance, and productivity. These products are indispensable tools in the establishment and sustenance of high-quality cell lines for applications in both research and biomanufacturing.

Cell Line Development Market- Geographical Insights

From a geographical standpoint, this market encompasses a wide array of regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Within these regions, individual countries play a significant role in fostering business activities. The demand for cell line development services and expertise has been steadily on the rise in the Asia-Pacific region. This trend can be attributed to a multitude of factors. Firstly, the burgeoning biotechnology and pharmaceutical sectors in the region have amplified the necessity for reliable cell lines to facilitate drug research and development efforts.

Cell Line Development Market- Competitive Landscape:

The competitive landscape in cell line development is a blend of well-established and emerging enterprises. Companies like Lonza, Thermo Fisher Scientific, and WuXi Biologics offer a comprehensive suite of services and technologies. They engage in competition by showcasing technical innovation, scale, and expertise. On the other hand, smaller firms like Selexis and Solentim focus on specific niches, delivering specialized solutions and cutting-edge platforms.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL LINE DEVELOPMENT MARKET KEY PLAYERS

  • Lonza
  • Thermo Fisher Scientific
  • WuXi Biologics
  • Catalent
  • Selexis
  • Horizon Discovery
  • Sartorius
  • MilliporeSigma
  • Abcam
  • ATCC
  • Crown Bioscience
  • LakePharma
  • ProBioGen
  • Solentim
  • Horizon Therapeutics

GLOBAL CELL LINE DEVELOPMENT MARKET, BY PRODUCT

  • Reagent and Media
  • Equipment
  • Accessories and consumables
  • Services

GLOBAL CELL LINE DEVELOPMENT MARKET, BY TYPE OF CELL LINES

  • Recombinant cell lines
  • Hybridomas
  • Continuous cell lines
  • Primary cell lines

GLOBAL CELL LINE DEVELOPMENT MARKET, BY APPLICATION

  • Bioproduction
  • Drug discovery
  • Toxicity testing
  • Tissue engineering
  • Others

GLOBAL CELL LINE DEVELOPMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell Line Development Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell Line Development Market Snippet by Product
    • 2.1.2. Cell Line Development Market Snippet by Type of Cell Lines
    • 2.1.3. Cell Line Development Market Snippet by Application
    • 2.1.4. Cell Line Development Market Snippet by Country
    • 2.1.5. Cell Line Development Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell Line Development Key Market Trends

  • 3.1. Cell Line Development Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell Line Development Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell Line Development Market Opportunities
  • 3.4. Cell Line Development Market Future Trends

4. Cell Line Development Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell Line Development Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cell Line Development Market Landscape

  • 6.1. Cell Line Development Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell Line Development Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 7.1.2. Reagent and Media
    • 7.1.3. Equipment
    • 7.1.4. Accessories and consumables
    • 7.1.5. Services

8. Cell Line Development Market - By Type of Cell Lines

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type of Cell Lines, 2022 & 2030 (%)
    • 8.1.2. Recombinant cell lines
    • 8.1.3. Hybridomas
    • 8.1.4. Continuous cell lines
    • 8.1.5. Primary cell lines

9. Cell Line Development Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Bioproduction
    • 9.1.3. Drug discovery
    • 9.1.4. Toxicity testing
    • 9.1.5. Tissue engineering
    • 9.1.6. Others

10. Cell Line Development Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cell Line Development Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cell Line Development Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cell Line Development Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cell Line Development Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cell Line Development Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Cell Line Development Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Lonza
    • 11.2.2. Thermo Fisher Scientific
    • 11.2.3. WuXi Biologics
    • 11.2.4. Catalent
    • 11.2.5. Selexis
    • 11.2.6. Horizon Discovery
    • 11.2.7. Sartorius
    • 11.2.8. MilliporeSigma
    • 11.2.9. Abcam
    • 11.2.10. ATCC
    • 11.2.11. Crown Bioscience
    • 11.2.12. LakePharma
    • 11.2.13. ProBioGen
    • 11.2.14. Solentim
    • 11.2.15. Horizon Therapeutics

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦